- Home
- ALLE vs ROIV Comparison
ALLE vs ROIV Comparison
Compare ALLE & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- ROIV
- Stock Information
- Founded
- ALLE 2013
- ROIV 2014
- Country
- ALLE Ireland
- ROIV United Kingdom
- Employees
- ALLE N/A
- ROIV N/A
- Industry
- ALLE Diversified Commercial Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ALLE Consumer Discretionary
- ROIV Health Care
- Exchange
- ALLE Nasdaq
- ROIV Nasdaq
- Market Cap
- ALLE 15.4B
- ROIV 14.0B
- IPO Year
- ALLE N/A
- ROIV N/A
- Fundamental
- Price
- ALLE $167.70
- ROIV $20.89
- Analyst Decision
- ALLE Hold
- ROIV Strong Buy
- Analyst Count
- ALLE 9
- ROIV 8
- Target Price
- ALLE $172.22
- ROIV $21.19
- AVG Volume (30 Days)
- ALLE 775.2K
- ROIV 9.3M
- Earning Date
- ALLE 10-23-2025
- ROIV 11-10-2025
- Dividend Yield
- ALLE 1.22%
- ROIV N/A
- EPS Growth
- ALLE 13.70
- ROIV N/A
- EPS
- ALLE 7.39
- ROIV N/A
- Revenue
- ALLE $3,979,700,000.00
- ROIV $20,329,000.00
- Revenue This Year
- ALLE $10.07
- ROIV N/A
- Revenue Next Year
- ALLE $6.55
- ROIV $320.50
- P/E Ratio
- ALLE $22.68
- ROIV N/A
- Revenue Growth
- ALLE 6.87
- ROIV N/A
- 52 Week Low
- ALLE $116.57
- ROIV $8.73
- 52 Week High
- ALLE $180.68
- ROIV $21.35
- Technical
- Relative Strength Index (RSI)
- ALLE 43.71
- ROIV 77.76
- Support Level
- ALLE $164.69
- ROIV $19.79
- Resistance Level
- ALLE $166.91
- ROIV $21.35
- Average True Range (ATR)
- ALLE 3.40
- ROIV 0.73
- MACD
- ALLE -0.16
- ROIV 0.09
- Stochastic Oscillator
- ALLE 41.65
- ROIV 83.67
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.